File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Update to the Hong Kong Epilepsy Guideline: evidence-based recommendations for clinical management of women with epilepsy throughout the reproductive cycle

TitleUpdate to the Hong Kong Epilepsy Guideline: evidence-based recommendations for clinical management of women with epilepsy throughout the reproductive cycle
香港腦癇指引更新:生殖週期中對腦癇婦女進行臨床管理的循證醫學建議
Authors
Issue Date2020
PublisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org/
Citation
Hong Kong Medical Journal, 2020, v. 26 n. 5, p. 421-431 How to Cite?
AbstractSince the publication of the Hong Kong Epilepsy Guideline in 2009, there has been significant progress in antiepileptic drug development. New AEDs have emerged, and data about their uses have been published. Women require special attention in epilepsy care. Drug teratogenicity, pregnancy, breastfeeding, contraception, reproduction technology, menopause, and catamenial epilepsy are major topics. Antiepileptic drugs should be chosen individually for patients who are pregnant or may become pregnant with consideration of their teratogenicity and seizure control properties. Folate is commonly prescribed for women of childbearing age who are taking antiepileptic drugs. Spontaneous vaginal delivery and breastfeeding are not contra-indicated in most cases but need to be considered individually based on the patient’s medical condition and wishes. Serum drug level monitoring of certain antiepileptic drugs during pregnancy and puerperium can guide dosage adjustment. For catamenial epilepsy, intermittent benzodiazepines such as clobazam during the susceptible phase of the menstrual cycle could be a treatment option.
自2009年發佈香港腦癇指引以來,抗腦癇藥的開發取得重大進展。新 的抗腦癇藥及其用途的數據已被發表。婦女在腦癇治療中需要特別留 意。藥物致畸性、懷孕、母乳喂養、避孕、生殖技術、更年期和月經 期腦癇是重要主題。考慮到其致畸性和腦癇發作控制特性,應為懷孕 或可能懷孕的患者個別選擇抗腦癇藥。葉酸通常用於服用抗腦癇藥的 育齡婦女。大多數情況下,自發陰道分娩和母乳喂養不是禁忌的,但 須根據患者的醫療狀況和意願作個別考慮。在妊娠和產褥期監測某些 抗腦癇藥的血清藥物水平可以指引劑量調整。對於月經性腦癇,在月 經週期的敏感階段間歇使用苯二氮卓類藥物(如氯巴沙姆)可作其中 一種治療選擇。
Persistent Identifierhttp://hdl.handle.net/10722/293392
ISSN
2020 Impact Factor: 2.227
2015 SCImago Journal Rankings: 0.279
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChang, RSK-
dc.contributor.authorLui, KHK-
dc.contributor.authorIp, W-
dc.contributor.authorYeung, E-
dc.contributor.authorYung, AWY-
dc.contributor.authorLeung, H-
dc.contributor.authorFung, ELW-
dc.contributor.authorFung, BBH-
dc.contributor.authorChan, ELY-
dc.contributor.authorPoon, TL-
dc.contributor.authorWong, HT-
dc.contributor.authorSiu, D-
dc.contributor.authorCheng, K-
dc.contributor.authorZhu, CXL-
dc.contributor.authorFong, GCY-
dc.contributor.authorChu, J-
dc.contributor.authorLui, CHT-
dc.contributor.authorYau, M-
dc.date.accessioned2020-11-23T08:16:05Z-
dc.date.available2020-11-23T08:16:05Z-
dc.date.issued2020-
dc.identifier.citationHong Kong Medical Journal, 2020, v. 26 n. 5, p. 421-431-
dc.identifier.issn1024-2708-
dc.identifier.urihttp://hdl.handle.net/10722/293392-
dc.description.abstractSince the publication of the Hong Kong Epilepsy Guideline in 2009, there has been significant progress in antiepileptic drug development. New AEDs have emerged, and data about their uses have been published. Women require special attention in epilepsy care. Drug teratogenicity, pregnancy, breastfeeding, contraception, reproduction technology, menopause, and catamenial epilepsy are major topics. Antiepileptic drugs should be chosen individually for patients who are pregnant or may become pregnant with consideration of their teratogenicity and seizure control properties. Folate is commonly prescribed for women of childbearing age who are taking antiepileptic drugs. Spontaneous vaginal delivery and breastfeeding are not contra-indicated in most cases but need to be considered individually based on the patient’s medical condition and wishes. Serum drug level monitoring of certain antiepileptic drugs during pregnancy and puerperium can guide dosage adjustment. For catamenial epilepsy, intermittent benzodiazepines such as clobazam during the susceptible phase of the menstrual cycle could be a treatment option.-
dc.description.abstract自2009年發佈香港腦癇指引以來,抗腦癇藥的開發取得重大進展。新 的抗腦癇藥及其用途的數據已被發表。婦女在腦癇治療中需要特別留 意。藥物致畸性、懷孕、母乳喂養、避孕、生殖技術、更年期和月經 期腦癇是重要主題。考慮到其致畸性和腦癇發作控制特性,應為懷孕 或可能懷孕的患者個別選擇抗腦癇藥。葉酸通常用於服用抗腦癇藥的 育齡婦女。大多數情況下,自發陰道分娩和母乳喂養不是禁忌的,但 須根據患者的醫療狀況和意願作個別考慮。在妊娠和產褥期監測某些 抗腦癇藥的血清藥物水平可以指引劑量調整。對於月經性腦癇,在月 經週期的敏感階段間歇使用苯二氮卓類藥物(如氯巴沙姆)可作其中 一種治療選擇。-
dc.languageeng-
dc.publisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org/-
dc.relation.ispartofHong Kong Medical Journal-
dc.relation.ispartof香港醫學雜誌-
dc.rightsHong Kong Medical Journal. Copyright © Hong Kong Academy of Medicine Press.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleUpdate to the Hong Kong Epilepsy Guideline: evidence-based recommendations for clinical management of women with epilepsy throughout the reproductive cycle-
dc.title香港腦癇指引更新:生殖週期中對腦癇婦女進行臨床管理的循證醫學建議-
dc.typeArticle-
dc.identifier.emailChang, RSK: skrchang@hku.hk-
dc.identifier.emailCheng, K: kfckevin@hku.hk-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.12809/hkmj198367-
dc.identifier.pmid33089787-
dc.identifier.scopuseid_2-s2.0-85093821922-
dc.identifier.hkuros318747-
dc.identifier.volume26-
dc.identifier.issue5-
dc.identifier.spage421-
dc.identifier.epage431-
dc.identifier.isiWOS:000600066300010-
dc.publisher.placeHong Kong-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats